Turmeric supplements offer little or no pain relief for knee arthritis
Turmeric supplements offer little or no pain relief for knee arthritis

Turmeric supplements may provide little or no pain relief for people with knee arthritis, according to a new Cochrane review. The international team of researchers found that the golden spice, which adds colour, flavour and nutrition to meals, does not ease symptoms as previously thought.

Review of nine studies

Turmeric contains compounds known as curcuminoids, including curcumin, which are anti-inflammatory and have been thought to help osteoarthritis, the most common form of arthritis. In the review of nine existing studies covering 1,245 people with knee osteoarthritis, researchers compared turmeric supplements with placebo, non-steroidal anti-inflammatory drugs such as ibuprofen and diclofenac, and paracetamol.

The studies investigated a range of turmeric extracts and curcuminoid-based products with different strengths and doses. People in the studies were aged 52 to 62 on average, around two-thirds were women, and the studies were conducted in Australia, Belgium, India and Thailand.

Limited effectiveness

Cochrane said the trials were relatively short, lasting between four weeks and three months. The combined results showed that compared to placebo and anti-inflammatory drugs, turmeric was not more effective. However, the team admitted some studies were limited and the available evidence remains uncertain.

Dr Ivan Shirinsky, lead author of the review and a practicing rheumatologist, said: “As a clinician and researcher, I am not surprised by these findings. Osteoarthritis is a complex and still incompletely understood disease. Despite intensive research, effective pharmacological treatment options remain limited, and many promising approaches have yielded limited or inconclusive evidence of clinical benefit.”

Trustworthiness of trials

Previous reviews have suggested turmeric may improve pain and physical function in people with osteoarthritis, but Cochrane raised concerns over the trustworthiness of 10 of these clinical trials and excluded them from the final analysis. Dr Shirinsky said: “This review highlights the importance of assessing the trustworthiness of clinical trials. Such assessments help identify studies that require further clarification before their findings can be used to inform conclusions about treatment effects.”